The Fifth Conference of IAOC “Current Status and Future of Anti-Cancer Targeted Therapies” will be held in Buenos Aires, Argentina in October 10^th and 11^th, 2013.

An outstanding faculty of speakers from the United States and Europe has committed in this meeting. Based on previous experience, we anticipate attendance by more than 900 scientists, practicing oncologists, basic and clinical, translational investigators and health care workers from all parts of Latin America, USA and Europe.

The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types.  The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development. The major emphasis will be on clinical aspects of cancer treatment in the 21^st century with discussion of significant scientific advances underlying the novel approaches still in preclinical development.

This meeting is the primary opportunity for oncologists and cancer related health workers to participate in a conference focusing on novel targeted therapies and other treatment advances which are changing the face of cancer care. 

The meeting does not charge a registration fee and the presentations are translated into Spanish in real time for the attendees.